These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9682909)

  • 1. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ouabain and hypothalamic, hypophysary inhibitory factor on rat mesangial cell proliferation.
    Montero A; Rodriguez-Barbero A; Ricote M; Sancho J; Lopez-Novoa JM
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S35-7. PubMed ID: 7508023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic hypophyseal inhibitory factor (HHIF) increases intrasynaptosomal free calcium concentration.
    Ricote M; Garcia-Martin E; Sancho J; Gutierrez-Merino C
    Hypertension; 1997 Jun; 29(6):1337-43. PubMed ID: 9180638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor.
    Sancho JM; Garcia-Martin E; Garcia-Robles R; Santirso R; Villa E; Gutierrez-Merino C; Ricote M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S32-4. PubMed ID: 7508022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypothalamic-hypophysary inhibitory factor on mesangial cell activation.
    Rodríguez-Barbero A; Martínez-Salgado C; Rodríguez-López AM; Ricote M; Sancho J; López-Novoa JM
    Hypertension; 1995 Dec; 26(6 Pt 1):905-11. PubMed ID: 7490147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus.
    Tymiak AA; Norman JA; Bolgar M; DiDonato GC; Lee H; Parker WL; Lo LC; Berova N; Nakanishi K; Haber E
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8189-93. PubMed ID: 8396262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity.
    Anner BM
    Clin Exp Hypertens; 1998; 20(5-6):489-97. PubMed ID: 9682905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brain Na+, K+-ATPase inhibitor (endobain E) enhances norepinephrine release in rat hypothalamus.
    Vatta M; Peña C; Fernández B; Rodríguez de Lores Arnaiz G
    Neuroscience; 1999 May; 90(2):573-9. PubMed ID: 10215160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]dizocilpine binding to N-methyl-D-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain.
    Reinés A; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Int; 2001 Oct; 39(4):301-10. PubMed ID: 11551670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of aspartate release by ascorbic acid and endobain E, an endogenous Na+, K+ -ATPase inhibitor.
    Bersier MG; Miksztowicz V; Peña C; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2005 Apr; 30(4):479-86. PubMed ID: 16076019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the structure of endogenous ouabain.
    Kawamura A; Guo J; Itagaki Y; Bell C; Wang Y; Haupert GT; Magil S; Gallagher RT; Berova N; Nakanishi K
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6654-9. PubMed ID: 10359767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
    Schneider R; Wray V; Nimtz M; Lehmann WD; Kirch U; Antolovic R; Schoner W
    J Biol Chem; 1998 Jan; 273(2):784-92. PubMed ID: 9422732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase.
    Silva VS; Nunes MA; Cordeiro JM; Calejo AI; Santos S; Neves P; Sykes A; Morgado F; Dunant Y; Gonçalves PP
    Toxicology; 2007 Jul; 236(3):158-77. PubMed ID: 17560001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the Ca2+,Mg(2+)-ATPase of sarcoplasmic reticulum by the hypothalamic hypophyseal inhibitory factor.
    Ricote M; García-Martín E; Sancho J; Gutiérrez-Merino C
    Biochim Biophys Acta; 1995 Dec; 1232(3):217-24. PubMed ID: 8534674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.